Search Results 11-20 of 23406 for autoimmune hepatitis

  1. Autoimmune hepatitis - Doctors and departments - Mayo Clinic

    This type of hepatitis happens when the immune system attacks the liver with destructive antibodies. Immune-suppressing medicine is the main treatment.

  2. Primary sclerosing cholangitis (PSC) - Symptoms and causes - Mayo Clinic

    Pediatric PSC begins in children or teens and can be accompanied by another condition called autoimmune hepatitis. ... Liver disease and failure. Long-term ...

  3. Fatty liver disease (MASLD) - Symptoms and causes - Mayo Clinic

    Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called nonalcoholic fatty liver disease (NAFLD), is a liver condition that ...

  4. Hepatitis B - Symptoms and causes - Mayo Clinic

    Chronic hepatitis B may not be detected for decades until a person becomes very ill from liver disease. Risk factors. The hepatitis B virus spreads through ...

  5. Hepatobiliary Clinic - Overview

    Alcoholic liver disease · Autoimmune hepatitis; Benign and malignant liver tumors; Budd-Chiari syndrome; Cholangiocarcinoma (bile duct cancer); Drug-induced ...

  6. Acute liver failure - Symptoms and causes - Mayo Clinic

    Liver failure can be caused by autoimmune hepatitis — a disease in which the ... If you have chronic liver disease, a history of any type of hepatitis ...

  7. Liver biopsy - Mayo Clinic

    Nonalcoholic fatty liver disease. · Chronic hepatitis B or C. · Autoimmune hepatitis. · Liver cirrhosis. · Primary biliary cholangitis. · Primary sclerosing ...

  8. Gastroenterology and Hepatology - Conditions treated - Mayo Clinic

    Autoimmune cholangitis; Autoimmune enteropathy; Autoimmune hepatitis · Autoimmune pancreatitis · Barrett's esophagus; Bile duct stones; Bile duct strictures ...

  9. A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of zetomipzomib in addition to standard-of-care in patients with autoimmune hepatitis (AIH) ...

  10. Human liver disease and the evolving role of CRISPR/Cas9 - Mayo Clinic

    In this Q&A, Kirk J. Wangensteen, M.D., Ph.D., explains how researchers are using CRISPR/Cas9 to study and develop new therapies for human liver diseases.